Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

421 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vascular complications after transcatheter aortic valve implantation: treatment modalities and long-term clinical impact.
Lunardi M, Pighi M, Banning A, Reimers B, Castriota F, Tomai F, Venturi G, Pesarini G, Scarsini R, Kotronias R, Regazzoli D, Maurina M, Nerla R, De Persio G, Ribichini FL. Lunardi M, et al. Among authors: ribichini fl. Eur J Cardiothorac Surg. 2022 Mar 24;61(4):934-941. doi: 10.1093/ejcts/ezab499. Eur J Cardiothorac Surg. 2022. PMID: 35188566
Effective plaque removal with a new 8 French-compatible atherectomy catheter.
Takagi T, Di Mario C, Stankovic G, Reimers B, Alberti A, Liistro F, Kovalenko O, Sgura F, Albiero R, Ribichini F, Pugno A, Colombo A. Takagi T, et al. Catheter Cardiovasc Interv. 2002 Aug;56(4):452-9. doi: 10.1002/ccd.10196. Catheter Cardiovasc Interv. 2002. PMID: 12124951
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).
Versaci F, Gaspardone A, Tomai F, Ribichini F, Russo P, Proietti I, Ghini AS, Ferrero V, Chiariello L, Gioffrè PA, Romeo F, Crea F; Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation Study. Versaci F, et al. J Am Coll Cardiol. 2002 Dec 4;40(11):1935-42. doi: 10.1016/s0735-1097(02)02562-7. J Am Coll Cardiol. 2002. PMID: 12475452 Free article. Clinical Trial.
Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study.
Tomai F, Reimers B, De Luca L, Galassi AR, Gaspardone A, Ghini AS, Ferrero V, Favero L, Gioffrè G, Prati F, Tamburino C, Ribichini F. Tomai F, et al. Diabetes Care. 2008 Jan;31(1):15-9. doi: 10.2337/dc07-1377. Epub 2007 Oct 1. Diabetes Care. 2008. PMID: 17909090 Clinical Trial.
Recurrent very late drug-eluting stent thrombosis.
Pesarini G, Arieti M, Spadaro R, Vassanelli C, Ribichini F. Pesarini G, et al. Cardiovasc Revasc Med. 2009 Apr-Jun;10(2):130-5. doi: 10.1016/j.carrev.2008.06.005. Cardiovasc Revasc Med. 2009. PMID: 19327678
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F, Tomai F, De Luca G, Boccuzzi G, Presbitero P, Pesarini G, Ferrero V, Ghini AS, Pastori F, De Luca L, Zavalloni D, Soregaroli D, Garbo R, Franchi E, Marino P, Minelli M, Vassanelli C. Ribichini F, et al. J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):192-9. doi: 10.2459/JCM.0b013e32831f9176. J Cardiovasc Med (Hagerstown). 2009. PMID: 19377384 Clinical Trial.
421 results